Revvity Inc. (RVTY)
Official siteHEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE
Market Cap: $17.24B
Last updated: Nov 17, 2026 at 11:05 AM ET
Revvity Inc. (RVTY) Financials: Revenue, Profit and Cash Flow
Revvity reported revenue of $2.86B for the fiscal year ended Dec 31, 2025, up 3.7% from the year before. That year, net income was $241.20M with a net margin of 8.4%, operating cash flow was $582.93M and free cash flow was $509.41M. The quarter ended Sep 30, 2026 had revenue of $728.90M and net income of $62.30M.
Revenue and Margins
The operating margin was 12.5% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $2.12B, a compound annual rate of 3.4%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $2.86B | +3.7% | 54.8% | 12.5% | 8.4% |
| Dec 2024 | $2.76B | +0.2% | 55.8% | 12.6% | 9.8% |
| Dec 2023 | $2.75B | -16.9% | 56.0% | 10.9% | 25.2% |
| Dec 2022 | $3.31B | -13.5% | 60.1% | 22.4% | 17.2% |
| Dec 2021 | $3.83B | +43.7% | 63.6% | 32.9% | 24.6% |
| Dec 2020 | $2.66B | -7.6% | 65.0% | 32.6% | 27.3% |
| Dec 2019 | $2.88B | +3.8% | 48.4% | 12.6% | 7.9% |
| Dec 2018 | $2.78B | +23.1% | 48.3% | 11.7% | 8.6% |
| Dec 2017 | $2.26B | +6.7% | 47.6% | 13.1% | 13.0% |
| Dec 2016 | $2.12B | N/A | 47.9% | 13.9% | 11.1% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 10.8% from the year before. In the quarter ended Sep 2026, net income rose 33.5% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.86B | $2.76B | $2.75B | $3.31B | $3.83B | $2.66B | $2.88B | $2.78B | $2.26B | $2.12B |
| Cost of revenue | $1.29B | $1.22B | $1.21B | $1.32B | $1.39B | $933.05M | $1.49B | $1.44B | $1.18B | $1.10B |
| Gross profit | $1.56B | $1.54B | $1.54B | $1.99B | $2.43B | $1.73B | $1.40B | $1.34B | $1.07B | $1.01B |
| Research and development | $215.84M | $196.84M | $216.58M | $221.62M | $200.34M | $146.44M | $189.34M | $194.00M | $139.46M | $124.18M |
| Operating income | $356.63M | $346.74M | $300.56M | $742.70M | $1.26B | $867.27M | $361.97M | $323.88M | $295.62M | $294.58M |
| Net income | $241.20M | $270.38M | $693.09M | $569.18M | $943.16M | $727.89M | $227.56M | $237.93M | $292.63M | $234.30M |
| EBITDA | $766.53M | $780.66M | $739.68M | $1.22B | $1.61B | $1.07B | $601.43M | $527.09M | $409.39M | $397.09M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $728.90M | $729.69M | $711.12M | $772.06M | $698.95M | $720.28M | $664.76M | $729.37M | $684.05M | $691.68M | $649.92M | $1.37B |
| Gross profit | $418.58M | $416.87M | $387.65M | $421.66M | $374.60M | $392.56M | $375.55M | $412.29M | $384.82M | $385.51M | $355.05M | $1.05B |
| Operating income | $95.14M | $89.32M | $75.89M | $111.75M | $81.90M | $90.76M | $72.23M | $118.75M | $98.15M | $85.72M | $44.12M | $77.16M |
| Net income | $62.30M | $51.82M | $40.72M | $98.36M | $46.65M | $53.95M | $42.24M | $94.64M | $94.37M | $55.36M | $26.01M | $78.56M |
Balance Sheet
As of Dec 2025, total debt of $3.22B exceeded cash and equivalents by $2.30B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $12.17B | $12.39B | $13.56B | $14.13B | $15.00B | $7.96B | $6.54B | $5.98B | $6.09B | $4.28B |
| Current assets | $2.24B | $2.35B | $3.00B | $3.29B | $2.44B | $2.24B | $1.37B | $1.23B | $1.20B | $1.19B |
| Cash and equivalents | $919.86M | $1.16B | $913.16M | $454.36M | $603.32M | $402.04M | $191.88M | $163.11M | $202.13M | $359.26M |
| Total liabilities | $4.92B | $4.73B | $5.69B | $6.75B | $7.86B | $4.22B | $3.72B | $3.39B | $3.59B | $2.12B |
| Short-term debt | $588.83M | $242.00K | $721.87M | $470.93M | $4.24M | $380.95M | $9.97M | $14.86M | $217.31M | $1.17M |
| Long-term debt | $2.63B | $3.15B | $3.18B | $3.92B | $4.98B | $1.61B | $2.06B | $1.88B | $1.79B | $1.05B |
| Shareholder equity | $7.25B | $7.67B | $7.87B | $7.38B | $7.14B | $3.74B | $2.81B | $2.58B | $2.50B | $2.15B |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $11.49B | $12.05B | $12.00B | $12.17B | $12.14B | $12.36B | $12.36B | $12.39B | $12.77B | $13.42B | $13.43B | $13.56B |
| Total liabilities | $4.22B | $4.82B | $4.81B | $4.92B | $4.76B | $4.81B | $4.72B | $4.73B | $4.85B | $5.55B | $5.59B | $5.69B |
| Cash and equivalents | $592.80M | $1.02B | $860.32M | $919.86M | $931.39M | $991.85M | $1.14B | $1.16B | $1.23B | $1.25B | $998.08M | $913.16M |
| Shareholder equity | $7.27B | $7.23B | $7.18B | $7.25B | $7.38B | $7.56B | $7.64B | $7.67B | $7.92B | $7.87B | $7.85B | $7.87B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 87.4% of operating cash flow. Dividends and share repurchases together came to 167.6% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $582.93M | $628.30M | $91.27M | $679.81M | $1.41B | $892.18M | $363.47M | $311.04M | $288.45M | $350.62M |
| Capital expenditures | $73.52M | $86.65M | $81.37M | $85.63M | $86.02M | $63.63M | $76.33M | $93.25M | $39.09M | $31.70M |
| Free cash flow | $509.41M | $541.65M | $9.90M | $594.18M | $1.32B | $828.54M | $287.14M | $217.78M | $249.36M | $318.91M |
| Dividends paid | $32.80M | $34.45M | $34.97M | $35.34M | $32.37M | $31.21M | $31.06M | $31.01M | $30.79M | $30.80M |
| Share repurchases | $820.82M | $369.58M | $388.88M | $80.64M | $73.07M | $6.94M | $6.31M | $57.45M | $3.83M | $151.80M |
| Investing cash flow | -$17.35M | $776.16M | $1.31B | -$132.85M | -$4.11B | -$504.50M | -$487.57M | -$159.86M | -$1.27B | -$83.88M |
| Financing cash flow | -$857.52M | -$1.13B | -$947.12M | -$661.80M | $2.94B | -$202.87M | $150.13M | -$179.23M | $782.24M | -$115.01M |
Quarterly
| Line item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $166.70M | $191.94M | $115.23M | $181.96M | $138.50M | $134.32M | $128.16M | $174.23M | $147.88M | $158.62M | $147.56M | $196.61M |
| Capital expenditures | $14.35M | $11.07M | $19.77M | $20.17M | $18.50M | $18.87M | $15.98M | $24.45M | $22.32M | $22.03M | $17.84M | $24.12M |
| Free cash flow | $152.36M | $180.87M | $95.45M | $161.79M | $120.00M | $115.45M | $112.17M | $149.78M | $125.57M | $136.59M | $129.72M | $172.50M |
Frequently Asked Questions About RVTY
What is Revvity's annual revenue?
Revvity reported revenue of $2.86B for the fiscal year ended Dec 31, 2025.
How fast is Revvity's revenue growing?
Revenue was up 3.7% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was -4.8%.
Is Revvity profitable?
Yes. Revvity reported net income of $241.20M for the fiscal year ended Dec 31, 2025, with a net margin of 8.4%.
How much free cash flow does RVTY generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $582.93M minus capital expenditures of $73.52M produced free cash flow of $509.41M.
How much debt does Revvity have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $2.63B, short-term debt of $588.83M and cash and equivalents of $919.86M.
RVTY pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts